{"id":"b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc","kind":"news","code":"b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc","name":"Biotechnology startup Tahoe Therapeutics raises USD 30 million to build living-cell AI models","nameBasis":"translated-title","summary":"On 2025/8/11, Forbes reported that biotechnology company Tahoe Therapeutics had raised USD 30 million at a USD 120 million valuation, bringing total funding to USD 42 million, with investment from Amplify Partners. It uses living-cell AI models to find new cancer treatments.","description":"","country":null,"category":null,"originalName":"生物技术初创公司Tahoe Therapeutics筹集了3000万美元以构建活细胞AI模型","eventDate":"2025-08-11T00:00:00.000Z","website":"https://www.forbes.com/sites/alexknapp/2025/08/11/biotech-startup-tahoe-therapeutics-raised-30-million-to-build-ai-models-of-living-cells/","sourceUpdatedAt":"2026-10-15T11:58:26.938Z","englishUpdatedAt":"2026-10-16T00:00:28.831Z","reviewedAt":"2026-10-16T00:00:28.831Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ffa75aa9390824528ffb850158ea80d553f06891927c48e58c74616dae3a0d36","companyId":"0475d7fd-fab7-4c67-bc32-05219226757f","foundedYear":null,"logoUrl":null,"originalText":"2025年8月11日，据Forbes报道，生物技术公司Tahoe Therapeutics完成3000万美元融资，估值达1.2亿美元，累计融资4200万美元，由Amplify Partners投资。该公司用活细胞AI模型寻找新癌症治疗方法。","sources":[{"url":"https://www.forbes.com/sites/alexknapp/2025/08/11/biotech-startup-tahoe-therapeutics-raised-30-million-to-build-ai-models-of-living-cells/","publishedOn":"2025-08-11T00:00:00.000Z"}],"related":[{"id":"21a56683-06cc-468b-a57b-b14ab16af620","kind":"institutions","code":"UB-I433","name":"AIX Ventures","nameBasis":"original-brand","summary":"Early-stage venture capital firm focused on AI.","description":"Early-stage venture capital firm focused on AI.","country":"United States","category":null,"originalName":"AIX Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:17.514Z","englishUpdatedAt":"2026-10-20T18:26:49.525Z","reviewedAt":"2026-10-20T18:26:49.525Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"65520ca545235c316843a85b091e2320c82a198e00ed52b7d48d96f86a20ad0a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/aix-ventures"},{"id":"69489f54-6d4e-43c1-b8e8-4c786bc19d3e","kind":"institutions","code":"UB-I038","name":"Amplify Partners","nameBasis":"original-brand","summary":"Amplify Partners, a US venture capital firm focused on startups from seed to growth stages.","description":"Amplify Partners, a US venture capital firm focused on startups from seed to growth stages.","country":"United States","category":null,"originalName":"Amplify Partners","eventDate":null,"website":"https://www.amplifypartners.com/","sourceUpdatedAt":"2026-10-20T01:00:11.936Z","englishUpdatedAt":"2026-10-20T18:26:56.597Z","reviewedAt":"2026-10-20T18:26:56.597Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"03fc25803bee97e957a96a06d06475e4255ad1def8e1f4eb8a16289467855fde","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/amplify-partners"},{"id":"3bfd17c2-6227-4cb4-9309-f86f0637e951","kind":"institutions","code":"UB-I1506","name":"Civilization Ventures","nameBasis":"original-brand","summary":"A venture capital firm focused on longevity science and healthcare.","description":"A venture capital firm focused on longevity science and healthcare.","country":"United States","category":null,"originalName":"Civilization Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T00:00:22.408Z","englishUpdatedAt":"2026-10-20T18:26:49.861Z","reviewedAt":"2026-10-20T18:26:49.861Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"43b5232e87d877f5221ea223d7b3c1d8bc1122dd96d0eae26aa613db51ae2fe2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/civilization-ventures"},{"id":"9b06f76c-6600-450d-80bc-73de41c059f9","kind":"institutions","code":"UB-I802","name":"Conviction Partners","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on developer tools and AI.","description":"An early-stage venture capital firm focused on developer tools and AI.","country":"United States","category":null,"originalName":"Conviction Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-20T07:00:17.820Z","englishUpdatedAt":"2026-10-20T18:27:02.971Z","reviewedAt":"2026-10-20T18:27:02.971Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"5284db6674df6e22f1d1f349710c6c93d97dc7e0938af1cd7e7e594f03be2822","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/conviction-partners"},{"id":"7f0b3c5b-f1f7-46e0-a92e-d75b33a525d5","kind":"institutions","code":"UB-I526","name":"Databricks Ventures","nameBasis":"original-brand","summary":"Databricks' corporate venture capital division.","description":"Databricks' corporate venture capital division.","country":"United States","category":null,"originalName":"Databricks Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:18.517Z","englishUpdatedAt":"2026-10-20T18:26:56.845Z","reviewedAt":"2026-10-20T18:26:56.845Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"45687bf37943f81a5d9a7cdfa7ad1a5ffbdae92e5f481f36f6e40abeb72da0f6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/databricks-ventures"},{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":"United States","category":null,"originalName":"General Catalyst","eventDate":null,"website":"https://generalcatalyst.com/","sourceUpdatedAt":"2026-10-20T07:00:15.404Z","englishUpdatedAt":"2026-10-20T18:27:03.248Z","reviewedAt":"2026-10-20T18:27:03.248Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"851a2e8828f240ae85d6f75ec01b2cce5155c9943842c6cb806148d2e4f3f908","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"dfccb46c-188f-40b9-93a0-4ada720fa1dc","kind":"institutions","code":"UB-I103","name":"Mubadala Investment Company","nameBasis":"original-brand","summary":"An Abu Dhabi sovereign wealth fund and global long-term institutional investor, allocating broadly to equities and alternative assets.","description":"An Abu Dhabi sovereign wealth fund and global long-term institutional investor, allocating broadly to equities and alternative assets.","country":null,"category":null,"originalName":"Mubadala Investment Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.833Z","englishUpdatedAt":"2026-10-15T21:35:19.526Z","reviewedAt":"2026-10-15T21:35:19.526Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7236c7a846813cf518984c274751509df94374195021d1a44039e6db11541b5c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/mubadala-investment-company"},{"id":"87eaf787-22ca-496e-b521-36d02b11b562","kind":"institutions","code":"UB-I1453","name":"Overlap Holdings","nameBasis":"original-brand","summary":"A venture capital and holding firm.","description":"A venture capital and holding firm.","country":"United States","category":null,"originalName":"Overlap Holdings","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T00:00:21.727Z","englishUpdatedAt":"2026-10-20T18:26:56.947Z","reviewedAt":"2026-10-20T18:26:56.947Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"acd3bed6506ce24853bc6b2c8e77b156b571cda906a7b52dcbc097c32d28d999","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/overlap-holdings"},{"id":"0475d7fd-fab7-4c67-bc32-05219226757f","kind":"companies","code":"UB-C6053","name":"Tahoe Therapeutics","nameBasis":"source-english","summary":"Live-cell data and virtual cell AI model research and development company.","description":"","country":null,"category":null,"originalName":"Tahoe Therapeutics","eventDate":null,"website":"https://www.tahoebio.ai/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:21:34.803Z","reviewedAt":"2026-10-20T18:21:34.803Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"e0a0c08b6ac2fa1e695003dd48c38e52d99b2e8021ae653a2dd0cb9f8f001ba0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/tahoe-therapeutics"},{"id":"1b3a29ae-9fe6-470b-aea9-7c283bf2203e","kind":"institutions","code":"UB-I1491","name":"WVC","nameBasis":"original-brand","summary":"WVC is an early-stage venture capital firm, focused on early-stage ventures.","description":"WVC is an early-stage venture capital firm, focused on early-stage ventures.","country":"United States","category":null,"originalName":"WVC","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T00:00:22.206Z","englishUpdatedAt":"2026-10-20T18:26:49.401Z","reviewedAt":"2026-10-20T18:26:49.401Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09e58dcd21d5d1daf7976ecc3f28ac584e70db989684905dc647b210d88a473a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/wvc"}],"path":"/news/b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Tahoe Therapeutics","path":"/companies/tahoe-therapeutics"}},"canonical":"https://uniquebase.ai/news/b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc"}